
Hot Topics in IPC: New Leadership, Tuberculosis, and COVID-19 Updates
In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on COVID-19, tuberculosis, and changes in leadership at the CDC and NIAID.
From new national health leadership to contaminants and a rise in COVID cases, there’s much to discuss this week.
New Leadership Within CDC and NIAID
One of the most challenging positions is working in public health leadership. Multiply that massively when a health crisis, like a pandemic, occurs. Leadership in the CDC and the National Institute of Allergy and Infectious Disease (NIAID). Learning the lessons of a pandemic and an unprecedented mpox outbreak will inherently change agencies, leadership, and strategy. For the CDC, this translated to new leadership following the departure of Rochelle Walensky, MD, MPH; Mandy Cohen, MD, MPH, is the new director of the CDC. Hailing from the North Carolina Department of Health and Human Services, her experience in public health leadership will be vital during this new phase in US health and pandemic preparedness.
When asked about one of the most significant issues within the U.S. and science, she noted
More recently, National Institutes of Health (NIH) announced the replacement of Anthony Fauci, MD, which was no easy feat. Jeanne
TB Contamination Related to Bone Grafts
Similar to what we saw in 2021, there is now an outbreak of tuberculosis linked to contaminated bone graft materials. Four cases and one death have already been
COVID-19 Cases Trending Up
With the new EG.5 variant on the rise, some recent cases and hospitalizations are worrisome for many experts. This is our fourth summer with COVID-19, and one thing we know is that summers often see a surge in cases. According to the
Related to this article








